EUROSTAD

The EUROSTAD study OBS14620 eDiary App has been developed for the Prospective Observational Study to characterise the medication history, demographic characteristics and previous treatment of Atopic Dermatitis (AD) in patients treated with systemic immunosuppressive therapy for AD.

The App will collect eDiary information for subjects registered into this study.

*Note: this App requires an activation code and can only be accessed by subjects who are participating in the OBS14620 trial.